Matches in Wikidata for { <http://www.wikidata.org/entity/Q92641465> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q92641465 description "article scientifique publié en 2019" @default.
- Q92641465 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92641465 description "scientific article published on 26 March 2019" @default.
- Q92641465 description "wetenschappelijk artikel" @default.
- Q92641465 description "наукова стаття, опублікована 26 березня 2019" @default.
- Q92641465 name "First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma" @default.
- Q92641465 name "First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma" @default.
- Q92641465 type Item @default.
- Q92641465 label "First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma" @default.
- Q92641465 label "First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma" @default.
- Q92641465 prefLabel "First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma" @default.
- Q92641465 prefLabel "First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma" @default.
- Q92641465 P1433 Q92641465-FD3294A9-C636-4884-8566-6F3737726741 @default.
- Q92641465 P1476 Q92641465-1D43C99E-EAC3-4BC3-89CE-EAB9B3DE0AFF @default.
- Q92641465 P2093 Q92641465-2DE0404F-1FD1-4D79-A81D-5B0BA1281AEF @default.
- Q92641465 P2093 Q92641465-39B6B5F0-B8E0-4FE9-A164-E0155772AC52 @default.
- Q92641465 P2093 Q92641465-668D2D8A-074B-46CB-A8BB-FD6A4B137C94 @default.
- Q92641465 P2093 Q92641465-674A1E92-91B6-425A-94C3-C490911BEE71 @default.
- Q92641465 P2093 Q92641465-A932897B-1888-4295-AE3F-D45219C1DDCB @default.
- Q92641465 P2093 Q92641465-B710AC4E-8871-4DE8-A1B4-50FE8E52E616 @default.
- Q92641465 P2093 Q92641465-C5714389-D5F4-4A1B-91B8-39B8D9A66586 @default.
- Q92641465 P2093 Q92641465-C7C796BD-9CA6-4906-9457-B45255E3B3D1 @default.
- Q92641465 P2093 Q92641465-F94DFB2D-0444-42F3-91DD-E0A29C535965 @default.
- Q92641465 P2093 Q92641465-FA5F6452-0D7F-418E-B643-3914E3C13B4C @default.
- Q92641465 P304 Q92641465-6DEE80B8-4AD7-4CAE-9727-B1F11C9E2D3E @default.
- Q92641465 P31 Q92641465-5C0E565C-0266-4650-8965-128B2A3DC451 @default.
- Q92641465 P356 Q92641465-57CA3A58-895F-4D31-8139-416237F48C87 @default.
- Q92641465 P433 Q92641465-150E0A2B-DE35-4E15-960E-F428F767FFDF @default.
- Q92641465 P478 Q92641465-583F10B0-6AB4-4411-9416-FB3596F08C17 @default.
- Q92641465 P577 Q92641465-A3639A31-B2AE-45EA-9821-838186812E85 @default.
- Q92641465 P698 Q92641465-33DA53BE-A500-4CA1-8A95-B41F32B56C9E @default.
- Q92641465 P921 Q92641465-85E103DA-A4FA-42F1-A1DC-09D3B5F44395 @default.
- Q92641465 P921 Q92641465-A7BE1944-EC19-44ED-B645-7A5EF019211B @default.
- Q92641465 P921 Q92641465-DAE98EAB-874A-4065-B01D-3738C6302671 @default.
- Q92641465 P356 S00280-019-03796-4 @default.
- Q92641465 P698 30915497 @default.
- Q92641465 P1433 Q326137 @default.
- Q92641465 P1476 "First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma" @default.
- Q92641465 P2093 "Albert Craig Lockhart" @default.
- Q92641465 P2093 "Christophe Massard" @default.
- Q92641465 P2093 "Erik Rasmussen" @default.
- Q92641465 P2093 "Gataree Ngarmchamnanrith" @default.
- Q92641465 P2093 "Haby Henary" @default.
- Q92641465 P2093 "Jean-Charles Soria" @default.
- Q92641465 P2093 "Jürgen Krauss" @default.
- Q92641465 P2093 "Michael Gordon" @default.
- Q92641465 P2093 "Sonal Patel" @default.
- Q92641465 P2093 "Vijay V Upreti" @default.
- Q92641465 P304 "1057-1063" @default.
- Q92641465 P31 Q13442814 @default.
- Q92641465 P356 "10.1007/S00280-019-03796-4" @default.
- Q92641465 P433 "6" @default.
- Q92641465 P478 "83" @default.
- Q92641465 P577 "2019-03-26T00:00:00Z" @default.
- Q92641465 P698 "30915497" @default.
- Q92641465 P921 Q1164529 @default.
- Q92641465 P921 Q323936 @default.
- Q92641465 P921 Q725307 @default.